Li Zhang, MD

Li Zhang, MD, is the deputy director of the Lung Cancer Research Center and a professor in the Medical Oncology Department at Sun Yat-sen University Cancer Center.

Articles by Li Zhang, MD

Cross Currents: ADCs After EGFR TKI Progression in EGFR-Mutated NSCLC

ByLi Zhang, MD

November 13th 2026

Li Zhang, MD, discusses OptiTROP-Lung04 and PANKU-Lung01, choosing between sac-TMT and iza-bren, and ADC practice in China and the US.

Dr Zhang on Sacituzumab Tirumotecan in Pretreated Advanced EGFR-Mutated NSCLC

ByLi Zhang, MD

June 11th 2025

Li Zhang, MD, discusses sacituzumab tirumotecan in patients with previously treated, advanced EGFR-mutated non–small cell lung cancer.

Li Zhang, MD

Articles by Li Zhang, MD

Cross Currents: ADCs After EGFR TKI Progression in EGFR-Mutated NSCLC

Dr Zhang on Sacituzumab Tirumotecan in Pretreated Advanced EGFR-Mutated NSCLC

Latest Updated Articles

Trending on OncLive

Cardiovascular and Bleeding Risk With BTK Inhibitors in CLL

FDA Approves Durvalumab Plus Enfortumab Vedotin for Cisplatin-Ineligible MIBC

Dr Calais on Individualizing PSMA-Targeted Therapy Sequencing in Prostate Cancer

CHMP Recommends Approval of Belzutifan Plus Lenvatinib for Advanced ccRCC After PD-(L)1 Inhibition

NDA Submission Completed for Zipalertinib Plus Chemotherapy in Frontline EGFR Exon 20 Insertion–Positive NSCLC